Thames Capital Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $5.65M | Hold |
13,927
| – | – | 1.28% | 30 |
|
2025
Q1 | $6.93M | Hold |
13,927
| – | – | 2.66% | 18 |
|
2024
Q4 | $7.25M | Hold |
13,927
| – | – | 1.96% | 22 |
|
2024
Q3 | $8.61M | Hold |
13,927
| – | – | 2.68% | 18 |
|
2024
Q2 | $7.7M | Hold |
13,927
| – | – | 3.02% | 20 |
|
2024
Q1 | $8.09M | Buy |
13,927
+725
| +5% | +$421K | 3.37% | 16 |
|
2023
Q4 | $7.01M | Hold |
13,202
| – | – | 3.61% | 13 |
|
2023
Q3 | $6.68M | Hold |
13,202
| – | – | 3.82% | 10 |
|
2023
Q2 | $6.89M | Hold |
13,202
| – | – | 3.67% | 12 |
|
2023
Q1 | $7.61M | Sell |
13,202
-15,989
| -55% | -$9.22M | 5.35% | 8 |
|
2022
Q4 | $16.1M | Sell |
29,191
-1,478
| -5% | -$814K | 7.63% | 5 |
|
2022
Q3 | $15.6M | Buy |
30,669
+1,819
| +6% | +$923K | 7.72% | 4 |
|
2022
Q2 | $15.7M | Hold |
28,850
| – | – | 6.29% | 4 |
|
2022
Q1 | $17M | Hold |
28,850
| – | – | 3.59% | 7 |
|
2021
Q4 | $19.3M | Sell |
28,850
-114
| -0.4% | -$76.1K | 3.69% | 5 |
|
2021
Q3 | $16.5M | Hold |
28,964
| – | – | 3.61% | 5 |
|
2021
Q2 | $14.6M | Hold |
28,964
| – | – | 3.43% | 6 |
|
2021
Q1 | $13.2M | Hold |
28,964
| – | – | 3.05% | 5 |
|
2020
Q4 | $13.5M | Hold |
28,964
| – | – | 3.79% | 5 |
|
2020
Q3 | $12.8M | Hold |
28,964
| – | – | 4.51% | 5 |
|
2020
Q2 | $10.5M | Hold |
28,964
| – | – | 4.12% | 5 |
|
2020
Q1 | $8.21M | Buy |
28,964
+114
| +0.4% | +$32.3K | 6.44% | 5 |
|
2019
Q4 | $9.37M | Sell |
28,850
-10,080
| -26% | -$3.27M | 3.11% | 11 |
|
2019
Q3 | $11.3M | Sell |
38,930
-13,930
| -26% | -$4.06M | 3.38% | 15 |
|
2019
Q2 | $15.5M | Buy |
52,860
+7,440
| +16% | +$2.18M | 4.39% | 10 |
|
2019
Q1 | $12.4M | Buy |
+45,420
| New | +$12.4M | 3.5% | 13 |
|